baber/WOPTO huggingface dataset:
Patent JP-3236625-B2 (JP)
IPC: B61C9/00
Filed: 1997-06-11
Granted: 2001-12-10
Abstract: The invention relates to a toothed coupling, especially a double toothed coupling, for rail vehicles, essentially consisting of a coupling housing (2) and at least one coupling component (3, 4) fitted inside the coupling housing (2), the coupling component has first teeth (9, 10) in its peripheral region (7) and the coupling housing has second teeth (11, 12) in its peripheral region (8) which form engaging teeth (13, 14) with the first teeth of the coupling component (3, 4) which are movable in relation to one another, and there is at least one annular disk-shaped support cover (21, 22) protecting the engaging teeth (13, 14) at the respective faces (19, 20) between the coupling housing (2) and the coupling component (3, 4). A toothed coupling is to be provided in which an exchange of media and, with the coupling rotating, irregular running, imbalance and wear of the sealing elements is prevented. To achieve this, there is at least one axial corrugated pipe (18, 47) positioned between the coupling housing (2; 5, 6) and each coupling component (3, 4) secured to at least one of both parts (2, 3; 2, 4 or 5, 3; 6, 4) which seals engaging teeth (13, 14) and also resiliently sets a predetermined position of the coupling housing (2; 5, 6).
Patent JP-3683587-B2 (JP)
IPC: A61M60/117
Filed: 1995-05-26
Granted: 2005-08-17
Abstract: A catheter system and devices for achieving total cardiopulmonary bypass during heart surgery are provided. The venous perfusion catheter has first and second balloons occluding the inferior and superior vena cava thereby precluding blood flow into the right atrium. An arterial perfusion catheter is inserted, advanced and positioned in the ascending aorta cephalid of the junction of the coronary arteries with the aortic root. A second flexible arterial cannula is mounted in sliding relationship with the first flexible cannula and carries an inflatable balloon adjacent its distal end to provide for occlusion of the ascending aorta. A first flexible cannula has a first lumen and an arterial venting orifice communicating with the first lumen defining a single flow path for the passage of cardioplegia solution to arrest the heart or for the evacuation of blood from the aortic root. A third lumen extends axially through the first flexible arterial cannula and communicates with a multiplicity of openings in the distal tip for suctioning blood from the left ventricle. The second flexible cannula of the arterial perfusion catheter has a first cavity extending axially therethrough that communicates with an opening at its distal tip to permit the passage of blood delivered by the cardiopulmonary bypass pump into arterial circulation. Both the venous and arterial perfusion catheters have a plurality of radially and oppositely spaced steering lumens and a plurality of steering cables fixed to the distal ends to achieve omnidirectional articulation. <IMAGE>
Patent JP-3035350-B2 (JP)
IPC: G01P9/00
Filed: 1991-11-22
Granted: 2000-04-24
Abstract: A magnetohydrodynmic angular rate sensor is described. A housing supports first and second coaxial proof masses in respective annular channels, permitting relative motion between the axis of the proof masses and the housings. First and second magnets associated with each annular channel result in an electric potential being generated across each channel proportional to the relative circumferential velocity between the proof masses and the housing. The annular channels are connected together to form a continuous pumped fluid circuit which introduces a radial flow velocity in each channel. At low rotational frequencies, a circumferential velocity component is induced in the proof masses due to Coriolis acceleration which results in a measurable electrical voltage across the annular channels. The low frequency response of the sensor is therefor extended to lower frequencies.
Patent JP-3313363-B2 (JP)
IPC: A61F5/44
Filed: 1990-12-07
Granted: 2002-08-12
Abstract: Disposable sanitary garments comprise topsheet and/or backsheet materials prepared from polymers based on dioxanone. Diapers, sanitary napkins, pantiliners, and the like, prepared from the foregoing materials are disclosed.
Patent JP-4051421-B2 (JP)
IPC: A61K38/14
Filed: 1996-06-25
Granted: 2008-02-27
Abstract: PCT No. PCT/EP96/02769 Sec. 371 Date Dec. 18, 1997 Sec. 102(e) Date Dec. 18, 1997 PCT Filed Jun. 25, 1996 PCT Pub. No. WO97/02288 PCT Pub. Date Jan. 23, 1997Method for purifying antibiotic compounds of the dalbaheptide family by means of isoelectric focusing (IEF) in a multicompartinent electrolyzer with immobiline membranes, in particular zwitterionic membranes. A further object of the invention are pure antibiotic compounds obtainable according to the present process, in particular the pure 6B-decarboxy-6B-(hydroxymethyl)-N63-3-(dimethylamino) propyl amide derivatives of antibiotic A40926.
Patent JP-4141503-B2 (JP)
IPC: A61B3/00
Filed: 1997-07-22
Granted: 2008-08-27
Abstract: An eye imaging system having a portable image capture unit having a circular light guide positioned adjacent to and behind a corneal contact lens for controlling directing light over a wide field to the retina of an eye and provide more light towards the center of the eye.
Patent JP-2948322-B2 (JP)
IPC: C10N40/20
Filed: 1995-08-09
Granted: 1999-09-13
Abstract: The present invention provides lubricant compositions for the powder metallurgical field. The lubricant compositions contain a solid phase lubricant such as graphite, molybdenum disulfide, and polytetrafluoroethylene in combination with a liquid phase lubricant that is a binder for the solid phase lubricant. The binder can be chosen from various classes of compounds including polyethylene glycols, polyethylene glycol esters, partial esters of C3-6 polyhydric alcohols, polyvinyl esters, and polyvinyl pyrrolidones. The binder is solubilized in an organic solvent.
Patent JP-3213329-B2 (JP)
IPC: A01C1/00
Filed: 1997-08-29
Granted: 2001-10-02
Abstract: A method and apparatus for treating seeds with self-organized avalanches of electrons between electrodes (11, 12) as a cathode and an anode with seeds (13) between the anode and cathode or on the anode. Apparatus circuit (200) in a box (20) provides simultaneous DC and AC between the electrodes which creates the avalanche of electrons which project into the seeds. The seeds must be stored before planting. The seeds so treated have enhanced growth characteristics.
Patent JP-2860171-B2 (JP)
IPC: F16L59/08
Filed: 1995-01-09
Granted: 1999-02-24
Abstract: A generally elongated, thin, metal sheet heat insulator (1) having at least two generally elongated, thin, metal sheets (3, 4, 5, 6 and 7) disposed generally one above the other in a spaced apart relationship and a metal separator (2) therebetween contacting both sheets for maintaining the spaced apart relationship. The improvement of the invention has distinct, non-woven, substantially open, metal separators (2) having a substantial Z-direction dimension (27) and have substantially parallel upper and lower contact surfaces (27, 29) spaced apart in the Z-direction (27) with a contact surface area of each contact surface less than about 30% of a planar area (48) of the separator parallel to the X and Y-dimensions of the separator.
Patent JP-3509867-B2 (JP)
IPC: H04Q11/04
Filed: 1995-01-24
Granted: 2004-03-22
Abstract: PCT No. PCT/GB95/00128 Sec. 371 Date Nov. 7, 1996 Sec. 102(e) Date Nov. 7, 1996 PCT Filed Jan. 24, 1995 PCT Pub. No. WO95/20846 PCT Pub. Date Aug. 3, 1995An Add-Drop Multiplexer (ADMUX) for use in a synchronous digital hierarchy telecommunication system is provided with a by-pass whereby, in use, it can be made to interface with a higher bit rate transmission system.
Patent JP-3017291-B2 (JP)
IPC: G01N33/49
Filed: 1995-01-23
Granted: 2000-03-06
Abstract: A density gradient medium for the isolation and enrichment of rare cells, including fetal nucleated erythrocytes from a peripheral blood sample is described. The medium comprises a colloidal density gradient medium dispersed in a meltable gel. In one aspect of the invention, the density gradient medium is hypertonic to facilitate separation of maternal red blood cells from fetal blood cells.
Patent JP-3933203-B2 (JP)
IPC: A45D26/00
Filed: 1996-11-19
Granted: 2007-06-20
Abstract: Depilation apparatus with a housing and a depilation member for gripping hairs on human skin and pulling the hairs from the skin comprises a vibration member for exerting mechanical vibrations on the skin. Such mechanical vibrations have an anaesthetizing effect on the skin so that pain sensations caused by the process of pulling hairs from the skin are relieved. The vibration member comprises flexible protrusions which have been disposed on a carrier. In this way, the mechanical vibrations are introduced into the skin in distinct concentrated positions on the skin.
Patent JP-4044615-B2 (JP)
IPC: A61P13/02
Filed: 1997-04-04
Granted: 2008-02-06
Abstract: The present invention relates to a phenylethanolaminotetralincarboxamide derivative represented by the general formula: <CHEM> (wherein A represents a lower alkylene group; B represents an amino group, a di(lower alkyl)amino group or a 3 to 7-membered alicyclic amino group which may contain an oxygen atom in the ring; the carbon atom marked with * represents a carbon atom in (R) configuration, (S) configuration or a mixture thereof; and the carbon atom marked with (S) represents a carbon atom in (S) configuration) and a pharmaceutically acceptable salt thereof, which have a selective beta 2-adrenergic receptor stimulating effect with relieved burdens on the heart such as tachycardia and are useful as an agent for the prevention of threatened abortion and premature labor, a bronchodilator, and an agent for pain remission and promoting stone removal in urolithiasis.
Patent JP-3976351-B2 (JP)
IPC: A61L2/00
Filed: 1998-04-06
Granted: 2007-09-19
Abstract: The invention relates to an immunotolerant prothrombin complex preparation, a method of producing this preparation, as well as the use of the preparation for producing a medicament,
Patent PL-162217-B2 (PL)
Title: Magnetron-type atomizing apparatus
Inventor: BALIKOJEW IGOR
IPC: C23C14/35
Filed: 1990-04-12
Abstract: 1. Magnetron-based atomizing device, consisting of a vacuum tank containing a cathode and anode, characterized in that the cathode (2) is divided into 3n sections which are mutually insulated from each other, where n is any natural number, while each of the sections of the cathode (2) is connected via a current limiting element (R) to one of the phases of a three-phase AC network, preferably 3 x 380V, 50 Hz.<IMAGE>
Patent ES-2237335-B2 (ES)
Title: Conector.
Inventor: IRISH KENNETH G
IPC: H01R13/514
Filed: 2004-03-03
Granted: 2006-04-16
Abstract: Un conector para conectar una pluralidad de hilos a un conjunto de casquillo de lámpara y conmutador en subminiatura que tiene lengüetas de contacto y una patilla de puesta a tierra incluye una carcasa moldeada de una pieza y una pluralidad de terminales para unir la pluralidad de hilos a las lengüetas de contacto y a la patilla de puesta a tierra. Una pluralidad de aberturas que están formadas dentro de la carcasa, aceptando tanto la pluralidad de terminales como las lengüetas de contacto y la patilla de puesta a tierra del conjunto, y permitiendo a los terminales conectarse con las lengüetas de contacto y la patilla de puesta a tierra. La pluralidad de aberturas están formadas dentro de las caras inferior, frontal y posterior de la carcasa. También se describe un procedimiento de conexión de un conjunto de casquillo de lámpara y conmutador en subminiatura que tiene lengüetas de contacto y una patilla de puesta a tierra a una pluralidad de hilos.
Patent AU-2001253191-B2 (AU)
Title: Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators
Inventor: MURPHY DENETTE K
IPC: A61P9/00
Filed: 2001-04-05
Granted: 2006-03-02
Abstract: This invention pertains to novel salt forms of trophenylethylene compound, such as 3-[4(1,2-diphenyl-but-1-enyl)-phenyl]-acrylic acid, as selective estrogen receptor modulators. This invention also provides methods for the treatment and/or prevention of breast, uterine, ovarian, prostrate and colon cancer, osteoporosis, cardiovascular disease, and benign proliferative disorders, as well as pharmaceutical compositions of the compounds of the present invention.
Patent AU-2001258827-B2 (AU)
Title: Method for examining WT1-related disease
Inventor: SUGIYAMA HARUO
IPC: G01N33/53
Filed: 2001-05-24
Granted: 2005-06-09
Abstract: The invention provides a method for testing a WT1-related disease, such as leukemia, a solid cancer, or an atypia, for diagnosing the disease, evaluating the course of cure and the prognosis of the disease more simply with high reliability, the method comprises measuring the amount of antibody against WT1 in a sample and using the measurement value and the time course of the value as a clinical marker for the testing.
Patent AU-2001296579-B2 (AU)
Title: Magnetic in situ dilution
Inventor: BAMDAD CYNTHIA C
IPC: G01N33/68
Filed: 2001-10-03
Granted: 2006-08-31
Abstract: Porous members can be positioned so as to partially or fully span channels in microfluidic systems. The porous members can be assembled and/or disassembled in situ. The porous members can be made such that pores are separated by connections including but a single molecule at one location, allowing for a high level of open area in a very small pore size member. The porous member can be made up of colloid particles interconnected with molecular species. These can be used to detect analytes qualitatively and/or quantitatively, or to selectively bind and/or release agents on command for a variety of purposes including first blocking, then opening a channel, concentrating analyte over time followed by release of analyte and detection downstream, etc. Porous members can define valves in multiple-channel systems and, with controlled binding and release of agents at the porous members, these valves can be opened and closed and fluid flow controlled in a multi-channel system. Fluidic systems of the invention can include multiple sensing locations at which different analytes are determined. Systems of the invention provide flexibility for overall microchemical analysis, sequentially, of a variety of agents.
Patent AU-2002302660-B2 (AU)
Title: Porous crystalline material (zeolite itq-21), the preparation method thereof and use of the same in the catalytic conversion of organic compounds
Inventor: GARCIA FERNANDO REY
IPC: B01J29/04
Filed: 2002-05-10
Granted: 2007-03-29
Abstract: Porous crystalline material comprises a low aluminum content and its calcinated form has a specific X-ray diffraction pattern. Porous crystalline material with the following chemical formula: X 2O 3: n YO 2 : m ZO 2 (I) (n + m) : at least 5; X : trivalent element; Z : Ge; Y : at least one tetravalent element other than Ge; and Y/Z : at least 1 and has an X-ray diffraction pattern with the following peaks: 13.64 (mf), 7.87 (mf), 4.82 (d), 4.82 (m), 4.55 (m), 4.11 (m), and 3.41 (m), the relative intensity for the lines is calculated as a percentage of the most intense peak. d (+-0.3) : interplanar distance (in Angstroms); mf : relatively high intensity of 80-100; m : a medium intensity of 40-60; and d : is a low tensity of 20-40. Independent claims are also included for the following: (1) method of preparing (I); and (2) method for converting a stock comprising at least one organic compound, by contact with a catalytically active quantity of (I).
Patent AU-2002305646-B2 (AU)
Title: TACI-immunoglobulin fusion proteins
Inventor: GROSS JANE A
IPC: C07K14/715
Filed: 2002-05-20
Granted: 2008-09-04
Abstract: Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.
Patent AU-2002366037-B2 (AU)
Title: Novel peptide having angiotensin convertase inhibitory effect
Inventor: YAMADA AKIO
IPC: A61P43/00
Filed: 2002-11-21
Granted: 2005-11-03
Abstract: A peptide Met-Lys-Pro, which is obtained by chemical synthesis ot hydrolysis of casein, is used as the active ingredient of angiotensin converting enzyme inhibitors or hypotensive drugs.
Patent AU-2003256036-B2 (AU)
Title: Method of diagnosis of pregnancy-related complications
Inventor: MEIRI HAMUTAL
IPC: G01N33/68
Filed: 2003-08-28
Granted: 2009-02-26
Abstract: A method for diagnosing pregnancy-related complications in a pregnant woman is provided. The method includes (a) providing a membrane phospholipid suspension; (b) exposing a first portion of the suspension to standard PP13; (c) exposing a second portion of the suspension to PP13 obtained from the woman; (d) measuring the production of prostaglandins in (b) and (c); and (e) comparing the amounts of prostaglandins produced in (b) and (c), a change in the amount of prostaglandins of (c) as compared to the amount of prostaglandins in (b) indicating the existence of a pregnancy-related complication in the woman.
Patent AU-2004203107-B2 (AU)
Title: Hand tool for inserting and removing rail fastenings
Inventor: ROUSSET BERNARD
IPC: E01B29/24
Filed: 2004-07-07
Granted: 2009-11-05
Abstract: The device has a turning part (4) mounted on the top of a main body (3) and a head (4b) formed on top of the turning part. An insertion cam (9) is mounted under the body for cooperating with rail fastenings. The head or the turning part is positioned angularly independent from the usage position of the cam to place a push bar (27) at the interior of a safety zone.
Patent AU-2004270186-B2 (AU)
Title: Stent graft, stent graft delivery system and kit and method for implanting the stent graft
Inventor: ARBEFEUILLE SAMUEL
IPC: A61F2/82
Filed: 2004-09-02
Granted: 2010-06-24
Abstract: A prosthesis implanting system includes a delivery sheath for receiving the prosthesis and delivering it to the treatment site and an alignment device on the sheath visible to a user for indicating a rotational and an axial position of the sheath with respect to the treatment site. The alignment device is part of a delivery assembly slidably disposed in a handle.
Patent AU-2004281239-B2 (AU)
Title: Carrier for sorting apparatus
Inventor: BERG WOUTER VAN DEN
IPC: B65G47/96
Filed: 2004-10-07
Granted: 2009-10-08
Abstract: An apparatus is provided for sorting products such as fruits. The apparatus comprises an endless conveyor and conveying units for conveying products behind each other in a substantially horizontal plane. Each conveying unit is formed by at least two rolling elements with the axes perpendicular to the conveying direction, a connecting element by which each rolling element is rotatably and vertically movably connected with the conveyor, and a carrier element arranged between the rolling elements, wherein at an inspection position, each product is situated on two successive rolling elements, and in a weighing position, each product is situated on the carrier element. A discharge guide comprises a leaf spring which has a rest position during conveyance and weighing, and a deflection position present only upon transition to and from a discharge position.
Patent AU-2004315770-B2 (AU)
Title: Use of public switched telephone network for capturing electronic signatures in on-line transactions
Inventor: ROLFE ANDREW R
IPC: G10L17/00
Filed: 2004-11-12
Granted: 2008-10-23
Abstract: A system for obtaining a digital signature incorporates two communication channels, and at least one of third-party data sources, geographic correlation algorithms, speech recognition algorithms, voice biometric comparison algorithms, and mechanisms to convert textual data into speech. A site visitor's identity can be verified using one or all of such features in combination with a visitors address on one of the channels.
Patent AU-2005247301-B2 (AU)
Title: FCγRIIB-specific antibodies and methods of use thereof
Inventor: EZIO BONVINI
IPC: C12N15/00
Filed: 2005-04-15
Granted: 2011-08-18
Abstract: The present invention relates to antibodies or fragments thereof that specifically bind FcγRIIB, particularly human FcγRIIB, with greater affinity than said antibodies or fragments thereof bind FcγRIIA, particularly human FcγRIIA. The present invention also provides the use of an anti-FcγRIIB antibody or an antigen-binding fragment thereof, as a single agent therapy for the treatment, prevention, management, or amelioration of a cancer, preferably a B-cell malignancy, particularly, B-cell chronic lymphocytic leukemia or non-Hodgkin's lymphoma, an autoimmune disorder, an inflammatory disorder, an IgE-mediated allergic disorder, or one or more symptoms thereof. The invention provides methods of enhancing the therapeutic effect of therapeutic antibodies by administering the antibodies of the invention to enhance the effector function of the therapeutic antibodies. The invention also provides methods of enhancing efficacy of a vaccine composition by administering the antibodies of the invention.
Patent AU-2005280278-B2 (AU)
Title: Low temperature Li/FeS2 battery
Inventor: WEBBER ANDREW
IPC: H01M6/16
Filed: 2005-08-22
Granted: 2010-12-09
Abstract: The invention is a 1.5 volt primary electrochemical battery cell with an alkali metal lithium negative electrode (such as lithium), a positive electrode (comprising iron disulfide for example) and a nonaqueous electrolyte. The electrolyte has a solute including lithium iodide dissolved in an ether-containing solvent including a 1,2-dimethoxypropane based solvent component and no more than 30 volume percent 1,2-dimethoxyethane. When 1,2-dimethoxypropane is used to replace at least most 1,2-dimethoxyethane in the solvent, the cell provides good discharge capacity at low temperature while maintaining excellent discharge capacity at room temperature.
Patent AU-2006200448-B2 (AU)
Title: Factor VII or VIIa-like molecules
Inventor: ANDERSON KIM VILBOUR
IPC: A61P11/00
Filed: 2006-02-02
Granted: 2009-11-12
Abstract: The present application relates to factor VII (FVII) or Factor VIIa (FVIIa) polypeptide conjugates, to their preparation and use in therapy, in particular for the treatment of a variety of coagulation-related disorders. These polypeptide conjugates comprise at least one non-polypeptide moiety covalently attached to a polypeptide, wherein the amino acid sequence of the polypeptide differs from that of wild-type FVII or FVIIa in that at least one amino acid residue comprising an attachment group for said non-polypeptide moiety has been introduced or removed. The conjugates of the present application have one or more improved properties as compared to commercially available rFVIIa, including increased functional in vivo half-life and/or increased plasma half-life, and/or increased bioavailability and/or reduced sensitivity to proteolytic degradation.
Patent AU-2006214278-B2 (AU)
Title: Lentiviral vectors and their use
Inventor: CHANG YUNG NIEN
IPC: A61K39/00
Filed: 2006-02-16
Granted: 2012-01-19
Abstract: The present invention relates to lentiviral vectors for gene therapy, cancer treatment, producing recombinant proteins, such as antibodies and vaccines, and other therapeutic purposes. Novel lentiviral vectors are disclosed, e.g., comprising helper sequences in opposite orientations and/or minimally functional LTR sequences, which can be used to prepare high efficiency transduction vectors. Vectors are also designed to express silencing RNA and antisense polynucleotides.
Patent AU-2006228094-B2 (AU)
Title: Low-calorie whole grain cereal bar
Inventor: SHARON BIRNEY
IPC: A23L27/00
Filed: 2006-10-16
Granted: 2011-08-04
Abstract: A low-calorie whole grain cereal bars is provided that includes whole grain and binder in amounts effective for providing a cereal bar with at least about 15 weight % or more whole grain, at least about 5 weight % or more protein, about 5 weight % or more fiber, and at least 120 or less calories per 28 gram bar. The cereal bars are low in calories but still provide a good source of whole grain and fiber while maintaining an acceptable taste and organoleptic properties.